Literature DB >> 25048553

Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death.

Ana P Castano1, Tatiana N Demidova2, Michael R Hamblin1.   

Abstract

Photodynamic therapy (PDT) has been known for over a hundred years, but is only now becoming widely used. Originally developed as a tumor therapy, some of its most successful applications are for non-malignant disease. In the second of a series of three reviews, we will discuss the mechanisms that operate in PDT on a cellular level. In Part I [Castano AP, Demidova TN, Hamblin MR. Mechanism in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2004;1:279-93] it was shown that one of the most important factors governing the outcome of PDT, is how the photosensitizer (PS) interacts with cells in the target tissue or tumor, and the key aspect of this interaction is the subcellular localization of the PS. PS can localize in mitochondria, lysosomes, endoplasmic reticulum, Golgi apparatus and plasma membranes. An explosion of investigation and explorations in the field of cell biology have elucidated many of the pathways that mammalian cells undergo when PS are delivered in tissue culture and subsequently illuminated. There is an acute stress response leading to changes in calcium and lipid metabolism and production of cytokines and stress proteins. Enzymes particularly, protein kinases, are activated and transcription factors are expressed. Many of the cellular responses are centered on mitochondria. These effects frequently lead to induction of apoptosis either by the mitochondrial pathway involving caspases and release of cytochrome c, or by pathways involving ceramide or death receptors. However, under certain circumstances cells subjected to PDT die by necrosis. Although there have been many reports of DNA damage caused by PDT, this is not thought to be an important cell-death pathway. This mechanistic research is expected to lead to optimization of PDT as a tumor treatment, and to rational selection of combination therapies that include PDT as a component.

Entities:  

Year:  2005        PMID: 25048553      PMCID: PMC4108176          DOI: 10.1016/S1572-1000(05)00030-X

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  187 in total

Review 1.  Regulation of T-cell apoptosis by reactive oxygen species.

Authors:  David A Hildeman
Journal:  Free Radic Biol Med       Date:  2004-06-15       Impact factor: 7.376

2.  Phthalocyanine 4-photodynamic therapy induces ceramide generation and apoptosis in acid sphingomyelinase-deficient mouse embryonic fibroblasts.

Authors:  S M Chiu; T W Davis; M Meyers; N Ahmad; H Mukhtar; D Separovic
Journal:  Int J Oncol       Date:  2000-02       Impact factor: 5.650

Review 3.  Death by a thousand cuts: an ever increasing list of caspase substrates.

Authors:  C Stroh; K Schulze-Osthoff
Journal:  Cell Death Differ       Date:  1998-12       Impact factor: 15.828

Review 4.  Inositol trisphosphate and diacylglycerol: two interacting second messengers.

Authors:  M J Berridge
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

Review 5.  Targeted therapies for cancer 2004.

Authors:  Jeffrey S Ross; David P Schenkein; Robert Pietrusko; Mark Rolfe; Gerald P Linette; James Stec; Nancy E Stagliano; Geoffrey S Ginsburg; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Journal:  Am J Clin Pathol       Date:  2004-10       Impact factor: 2.493

6.  Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells.

Authors:  Nico Hendrickx; Cédric Volanti; Ugo Moens; Ole Morten Seternes; Peter de Witte; Jackie R Vandenheede; Jacques Piette; Patrizia Agostinis
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

7.  Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages.

Authors:  S Evans; W Matthews; R Perry; D Fraker; J Norton; H I Pass
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

8.  Photodynamic inhibition of enzymatic detachment of human cancer cells from a substratum.

Authors:  Anatoly Uzdensky; Asta Juzeniene; Li-Wei Ma; Johan Moan
Journal:  Biochim Biophys Acta       Date:  2004-01-05

Review 9.  The role of proteasome inhibitors in solid tumors.

Authors:  David J Park; Heinz-Josef Lenz
Journal:  Ann Med       Date:  2004       Impact factor: 4.709

Review 10.  E2F and cell cycle control: a double-edged sword.

Authors:  Craig Stevens; Nicholas B La Thangue
Journal:  Arch Biochem Biophys       Date:  2003-04-15       Impact factor: 4.013

View more
  118 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.

Authors:  Luo-Wei Wang; Zheng Huang; Han Lin; Zhao-Shen Li; Fred Hetzel; Bolin Liu Md
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-01-30       Impact factor: 3.631

Review 3.  A review of progress in clinical photodynamic therapy.

Authors:  Z Huang
Journal:  Technol Cancer Res Treat       Date:  2005-06

Review 4.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

5.  Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-alkylpyridylporphyrins.

Authors:  Rima Ezzeddine; Anwar Al-Banaw; Artak Tovmasyan; James D Craik; Ines Batinic-Haberle; Ludmil T Benov
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

6.  Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.

Authors:  Karan Arora; Mackenzie Herroon; Malik H Al-Afyouni; Nicholas P Toupin; Thomas N Rohrabaugh; Lauren M Loftus; Izabela Podgorski; Claudia Turro; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2018-10-22       Impact factor: 15.419

7.  A Photosensitizer-Loaded DNA Origami Nanosystem for Photodynamic Therapy.

Authors:  Xiaoxi Zhuang; Xiaowei Ma; Xiangdong Xue; Qiao Jiang; Linlin Song; Luru Dai; Chunqiu Zhang; Shubin Jin; Keni Yang; Baoquan Ding; Paul C Wang; Xing-Jie Liang
Journal:  ACS Nano       Date:  2016-03-10       Impact factor: 15.881

8.  Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle.

Authors:  María García-Díaz; Masayoshi Kawakubo; Pawel Mroz; M Lluïsa Sagristà; Margarita Mora; Santi Nonell; Michael R Hamblin
Journal:  J Control Release       Date:  2012-07-27       Impact factor: 9.776

9.  Protection effect of GDNF and neurturin on photosensitized crayfish neurons and glial cells.

Authors:  Anatoly Uzdensky; Maxim Komandirov; Grigory Fedorenko; Andrej Lobanov
Journal:  J Mol Neurosci       Date:  2012-07-31       Impact factor: 3.444

10.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.